Department of Radiation Oncology, Florence Nightingale Gayrettepe Hospital, Istanbul, Turkey.
Br J Radiol. 2010 Dec;83(996):1072-6. doi: 10.1259/bjr/25788274.
The aim of this study is to evaluate the coverage of axillary nodal volumes with high tangent fields (HTF) in breast radiotherapy and to determine the utility of customised blocking. The treatment plans of 30 consecutive patients with early breast cancer were evaluated. The prescription dose was 50 Gy to the whole breast. Axillary level I-II lymph node volumes were delineated and the cranial border of the tangential fields was set just below the humeral head to create HTF. Dose-volume histograms (DVH) were used to calculate the doses received by axillary nodal volumes. In a second planning set, HTF were modified with multileaf collimators (MLC-HTF) to obtain an adequate dose coverage of axillary nodes. The mean doses of the axillary nodes, the ipsilateral lung and heart were compared between the two plans (HTF vs MLC-HTF) using a paired sample t-test. The doses received by 95% of the breast volumes were not significantly different for the two plans. The doses received by 95% of the level I and II axillary volumes were 16.79 Gy and 11.59 Gy, respectively, for HTF, increasing to 47.2 Gy and 45.03 Gy, respectively, for MLC-HTF. Mean lung doses and per cent volume of the ipsilateral lung receiving 20 Gy (V20) were also increased from 6.47 Gy and 10.47%, respectively, for HTF, to 9.56 Gy and 16.77%, respectively, for MLC-HTF. Our results suggest that HTF do not adequately cover the level I and II axillary lymph node regions. Modification of HTF with MLC is necessary to obtain an adequate coverage of axillary levels without compromising healthy tissue in the majority of the patients.
本研究旨在评估乳腺癌放射治疗中高位切线野(HTF)对腋窝淋巴结区域的覆盖情况,并确定定制挡块的应用价值。对 30 例早期乳腺癌患者的治疗计划进行了评估。处方剂量为全乳 50Gy。勾画腋窝 I-II 区淋巴结体积,切线野颅侧边界设定在肩峰下方,以创建 HTF。利用剂量体积直方图(DVH)计算腋窝淋巴结区域接受的剂量。在第二个计划集,利用多叶准直器(MLC-HTF)修改 HTF,以获得腋窝淋巴结的足够剂量覆盖。采用配对样本 t 检验比较两种计划(HTF 与 MLC-HTF)中腋窝淋巴结、同侧肺和心脏的剂量均值。两种计划中 95%的乳腺体积接受的剂量没有显著差异。HTF 时腋窝 I-II 区 95%体积接受的剂量分别为 16.79Gy 和 11.59Gy,而 MLC-HTF 时分别增加至 47.2Gy 和 45.03Gy。同侧肺的平均剂量和接受 20Gy 的体积百分比(V20)也从 HTF 时的 6.47Gy 和 10.47%分别增加到 MLC-HTF 时的 9.56Gy 和 16.77%。我们的结果表明,HTF 不能充分覆盖腋窝 I-II 区淋巴结区域。为了在大多数患者中获得腋窝水平的足够覆盖而不损害健康组织,需要用 MLC 对 HTF 进行修改。